Search
About WifOR
Research
Health
Burden of Disease
Health Economy Reporting
Social Impact
Sustainability
Economic and R&D Footprint
Environmental Footprint
Impact Valuation
Scope 3 Assessment
Social Hotspot Analysis
WISIT – the WifOR Institute Sustainability Impact Tool
Labor Market
Big Data Skills Analysis
Employer Attractiveness Analysis
Diversity, Equity & Inclusion
Skilled Labor Analysis
Data packages
GHG Emission Factors
Spend-based Multipliers for Sustainability Analysis
Value Factors
Publications
Newsroom
Career
DE
EN
Contact
Latest publications
Journal publication
Dr. Malina Müller, Hannah Lintener, Vivien Henkel, Andreas Pilz, Kate Halsby, Claudius Malerczyk, Harish Madhava, Jennifer C. Moïsi, Holly Yu, Katharina Schley
10/2024
Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany
Method paper
Dr. Richard Scholz, Dr. Nora Albu, Dr. Daniel Croner, Dr. Zarko Kalamov, Lukas Mai, Dr. Silvia Forin, Jasmin Tesch, Tabea Dorndorf, Jana Setzer
03/2025
WifOR Impact Valuation
Study
Mani Juneja, Lukas Mai, Dr. Nora Albu
11/2024
The Economic Impact of the Global Pharmaceutical Industry
Library
Research area
Career
Health
Labor Market
Newsletter
Sustainability
Publication type
Conference poster
Journal publication
Method paper
Scientific article
Study
Conference poster
2019
The Social Impact of Erenumab in Prophylactic Treatment of Patients with Migraine in Germany: A Macroeconomic Open-Cohort Approach
Ahmed Seddik, Claudio Schneider, Jennifer Branner, Prof. Dr. Dennis Ostwald, Dr. Jasper Huels
Conference poster
2019
German Cost Analysis of Triplet Regimens for Relapsed or Refractory Multiple Myeloma Patients
Dr. Mathias Kappel, Dr. Arpit Misra, Edin Basic, Janine Pöpper, Boris A. Ratsch, Prof. Dr. Dennis Ostwald
Journal publication
2019
The societal impact of Erenumab in prophylactic treatment of patients with migraine in Germany: a macroeconomic open-cohort approach
Ahmed Seddik, Ahmed Seddik, Claudio Schneider, In collaboration with Dr. Jasper Huels (Novartis), Jennifer Branner, Prof. Dr. Dennis Ostwald
Journal publication
2019
German cost analysis of triplet regimens for relapsed or refractory multiple myeloma patients
Dr. Arpit Misra, Dr. Mathias Kappel, In collaboration with Boris A. Ratsch (Takeda), In collaboration with Edin Basic (Takeda), Janine Pöpper, Prof. Dr. Dennis Ostwald
Study
2019
The Social Impact of Novartis medicines: Two Case Studies from South Africa and Kenya
Ahmed Seddik, Ahmed Seddik, Jennifer Branner, Prof. Dr. Dennis Ostwald, Remon Helmy
Study
2019
The Environmental Impact of Novartis Along Global Supply Chains
Dr. Marcus Cramer, Dr. Richard Scholz, In collaboration with Sonja Haut (Novartis), Natalia Benke, Nora Albu, Prof. Dr. Dennis Ostwald
‹
1
…
11
12
13
14
15
16
›
Interested in our newsletter?
Sign Up Here
Interested in our newsletter?
Sign Up Here
